- Home
- / Apogee Therapeutics
Apogee Therapeutics
Stock Price
$56.3
2024-10-29
Market Capitalization
$3.1 B
2024-10-29
Apogee Therapeutics Summary
Company Summary
- Overview
- Apogee Therapeutics is a biotechnology company developing therapies to address the needs of people with immunological and inflammatory disorders.
- Type
- Public
- Status
- Active
- Founded
- 2022
- HQ
- Waltham, MA, US | view all locations
- Cybersecurity rating
- Sectors
Table of Contents
Key People
Michael Henderson, Chief Executive Officer
Mehrak Kiankarimi, SVP, Program Management & Operations
Jane Pritchett Henderson, Chief Financial Officer
LocationsView all
1 location detected
Waltham, MA HQ
United States
221 Crescent St Building 17, Suite 102b
Apogee Therapeutics Financials
Summary Financials
- Net income (Q1, 2026)
- ($74.1M)
- Cash (Q1, 2026)
- $451.8M
- EBIT (Q1, 2026)
- ($82.8M)
- Enterprise value
- $2.7B